PharmChem
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PharmChem's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3% to $6,012,403. Profit margin reached 14%. Total operating expenses were $2,931,229.

Profit Margin

PharmChem, Inc. (OTC:PCHM): Profit margin
2017 4.69M 1.17M 25.12%
2019 5.54M 1.71M 31.02%
2020 6.66M 1.96M 29.41%
2021 6.22M 1.85M 29.78%
2022 5.83M 870.43K 14.91%
2023 6.01M 845.10K 14.06%

PCHM Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2017
Revenue
Revenue
6.01M5.83M6.22M6.66M5.54M4.69M
Cost of revenue
2.10M2.09M2.32M2.45M2.11M1.75M
Gross profit
3.90M3.74M3.89M4.21M3.42M2.93M
Operating exp.
Research and development
2.45K00000
Selling and marketing
000000
Total operating expenses
2.93M2.66M2.34M2.07M1.79M1.70M
Operating income
973.14K1.08M1.54M2.14M1.63M1.23M
Other income (expenses), net
80.49K24.53K128.65K22.82K99.37K2.08K
Income before tax
1.05M1.10M1.67M2.16M1.73M1.23M
Income tax expense
208.53K235.79K-178.92K201.97K13.5K55.68K
Net income
845.10K870.43K1.85M1.96M1.71M1.17M
Earnings per share
Basic EPS
0.170.170.320.340.290.2
Diluted EPS
0.170.160.280.280.250.2